September 3, 2014

FDA Violates Federal Law: Emord and ANH Challenge Illegal Rulemaking

pin it button FDA Violates Federal Law: Emord and ANH Challenge Illegal Rulemaking

Respect for Law low res FDA Violates Federal Law: Emord and ANH Challenge Illegal Rulemaking

by Alliance for Natural Health

Bolstered by a massive outpouring of support from you, we are asking the agency to withdraw its New Dietary Ingredient (NDI) draft guidance completely!

The period for comments to the FDA on the draft guidance on NDI notifications closed on December 2. Along with the hundreds of thousands of messages you sent and the 20,000 phone calls you made to FDA and Congress, ANH-USA also submitted formal comments.

The problem with the FDA’s draft guidance on New Dietary Ingredients is that it allows FDA to arbitrarily deny the sale of any supplement created (or modified) in the past seventeen years. If you’re a supplement manufacturer or distributor or possibly even a health food store, and you don’t file a NDI “notification” (actually a request for approval) for each ingredient in each product developed since 1994 in just the way prescribed by the FDA, and the court later decides the FDA is right, then you are guilty of product “adulteration,” which is punishable by prison. With your favorite supplements off the market, it also would allow the drug industry to adapt and patent them, and sell them back to you—by doctor’s prescription only—for 10 or 100 (or even more) times what you’re paying now.

Our comments, drafted by acclaimed attorney Jonathan Emord on our behalf, show that the FDA is engaged in substantive new rulemaking, in violation of the federal Administrative Procedure Act (APA). “The APA says if an agency’s action is legislative in nature, that’s rulemaking,” explained Emord. “The guidance distorts the plain language of the laws that govern supplements. FDA needs to comply with the APA’s formal rulemaking requirements, not issue unilateral guidance as a deceptive means of creating new rules.”

We argue that the FDA is acting illegally. The FDA circumvented the regulatory process by issuing a guidance, which gives them cover and flexibility, instead of going through the rulemaking process, which is required when creating a new law—and we believe the guidance in fact does create new law. As a result, FDA’s actions leave interested parties little recourse within the regulatory system.

In technical terms, a guidance is supposed to be legally non-binding. It is meant to simply present the FDA’s interpretation of the rule. However, the NDI guidance goes well beyond an interpretation, and we believe it is in fact a legislative rule with legal implications:

  • The NDI guidance is a departure from the FDA’s previous standards for NDI notifications. It alters and broadens the meaning of what qualifies as an NDI, and creates new—and very expensive—requirements to comply with the NDI notification process (creating what we would call a de facto pre-approval system), counter to what is outlined in Dietary Supplement Health and Education Act (DSHEA).
  • Not fulfilling the NDI notification requirements outlined in the guidance ensures that the supplement will be considered adulterated and therefore illegal. This indicates there’s a clear, legally binding impact to the NDI guidance.
  • Supplements that are considered illegal can be confiscated, and under the Food Safety Modernization Act, as we noted lasted week, can now be subject to administrative detention as well.

You may recall that Joanna M. Shepherd Bailey, PhD, professor of law and economics at Emory University, demonstrated that FDA grossly underestimated the economic cost of the NDI guidance. Her report found that:

  • Between 22,240 and 41,700 nutritional supplements would likely be removed from the market, at an economic loss of between $5.6 billion and $10.5 billion;
  • The nutritional supplement market could shrink by between 28% and 52.5%, producing an annual loss for the industry of between $7.84 billion to $14.7 billion; and
  • Between 55,720 and 104,475 jobs in the supplement industry could be lost.

FDA’s analysis did not take into consideration the costs of the expanded reach and requirements of the NDI guidance. The agency therefore misled the Office of Management and Budget, in violation of the Paperwork Reduction Act of 1996.

FDA has arbitrarily determined that supplement companies need to show at least “25 years of widespread use” in order it to meet the “history of safety” standard in NDI notification. In other words, only supplements on the market before October 1986 could be considered “safe.” This is patently ridiculous, since the cutoff date for grandfathered ingredients assumed to be safe, according to DSHEA, is October 1994.

The NDI notification system was intended to ensure safety. The very reason pre-DSHEA supplements were grandfathered is because they had proven themselves safe through years of use by hundreds of thousands of consumers! If safety is of utmost concern to FDA, why does the guidance document burden the supplement industry with regulatory requirements that have nothing to do with proving the safety of the supplements? It appears FDA is acting out of spite—and not in the public’s best interest. Moreover, many of the provisions in the guidance are totally unrelated to safety and serve only to limit consumers’ access to nutritional supplements.

We believe FDA will be unable incorporate enough changes to their draft guidance to bring it in line with existing law, preserve supplement access for customers, and remove needless regulatory hurdles for industry. Because of this, we asked FDA in our formal comments to withdraw the draft guidance at the earliest possible moment.

Now that the FDA’s comment period is closed, the agency is supposed to review the comments and prepare a final version of the guidance document—though they are under no legal obligation to do so. In fact, because it is guidance, they are under no legal obligation even to take public comments into consideration. Nor is there any timeline: the agency is still sitting on a guidance, now nearly three years old, that was meant to create a distinction between beverages and liquid dietary supplements.

Even worse, since this is presented as guidance and not formal rulemaking, the FDA is very likely to enforce the provisions in the draft guidance as though they were final—with limited legal recourse for affected parties!

We believe FDA’s actions require them to follow the Administrative Procedure Act, which calls for a formal rulemaking procedure. Under this law:

  • FDA will be forced to have a formal comment period, and to review and consider all comments before they issue a final rule. This includes a rulemaking record that shows the data and analysis behind a proposed rule, and sometimes even public hearings.
  • If the result is not to the liking of interested parties, “Each agency shall give an interested person the right to petition for the issuance, amendment, or repeal of a rule.” This means, that unlike a guidance, it is possible to challenge a rule in court. It is very likely that FDA conveniently issued a guidance, instead of going through the rulemaking process, to avoid this very outcome.

Now that the NDI comment period is closed, we will start implementing the next phase of our strategy—which will include both legal and legislative components. We will, of course, keep our supporters and allies in the loop.

Thank you all again for your tremendous outpouring of letters and phone calls! It has laid important groundwork for our next actions.

Read the Full Article Here: http://www.anh-usa.org/fda-violates-federal-law/

Global Censorship of Health Information
The Politics of Controlling Therapeutic Information to Protect State-Sponsored Drug Monopolies

Global Censorship of Health Information book coversm FDA Violates Federal Law: Emord and ANH Challenge Illegal Rulemaking

by Attorney Jonathan Emord
Free Shipping available!

0 commentsback to post

Other articlesgo to homepage

Study: Legalizing Medical Marijuana Leads to Fewer Prescription Drug Overdose Deaths

Study: Legalizing Medical Marijuana Leads to Fewer Prescription Drug Overdose Deaths

Pin It

A study published in the journal JAMA Internal Medicine on Monday found that states that had legalized medical marijuana had seen a 25 percent drop in deaths related to prescription drug overdoses.

According to ABC News, the researchers conducting the study found that because “legalizing medical marijuana makes it more available to chronic pain patients, it provides a potentially less lethal alternative to pain control on a long-term basis.”

Over the course of the study, the states studied were the ones that allowed access to medical marijuana. The Washington Post reported that those states “had 1,729 fewer overdose deaths in 2010 than would be predicted by trends in states without such laws.”

Dr. Marcus Bachhuber, a physician and researcher at the University of Pennsylvania, and the lead author of the study, told ABC News that while he did expect to see changes among the states that legalized medical marijuana, he found it “surprising that the difference is so big.”

Unapproved but Effective Cancer Cures

Unapproved but Effective Cancer Cures

Pin It

The conventional cancer treatment system and the pharmaceutical companies that control it are dedicated to limiting the development of all other forms of cancer treatment. They have a chokehold on the development of alternative treatments, and they ruthlessly work together with the US FDA and various US government cancer research funding agencies to prevent new treatments from being approved for use by physicians. The reason is that most alternative cancer treatments are much less expensive than surgery, radiation, and chemo. They are also more effective and have many fewer (if any) unwanted side effects.

The great fear of the pharmaceutical industry, and the vast cancer treatment system that it controls, is that a non-patentable and inexpensive cure for cancer might put them out of business. Sadly, these organizations exist to turn a profit from cancer treatment, which is measured in the billions of dollars every year. They are in the business of treating cancer not curing it.

Alternative treatments for cancer have a history of curing cancer and it is this fact that big pharma wants to hide from the American public. Historically, many successful approaches have been developed for curing cancer. We give a review of many of the most popular ones here.

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

Pin It

US consumers are in dark about mercury in dental products—and they are kept there deliberately by the government. This is documented in a new report being released this week by Consumers for Dental Choice called “Measurably Misleading: Evidence the FDA and Dental Industry are Deliberately Deceiving American Families about Mercury Dental Fillings and Why That Now Has International Consequences.”

Mercury is a known neurotoxin, yet mercury fillings presents one of the largest consumer consumption of mercury worldwide, and dental amalgam represents the largest use of mercury in consumer products in the US. We’ve also been kept in in the dark about mercury in other consumer products because of the FDA. Thimerosal, a mercury compound often found in flu vaccines, is being ignored as a danger.

Detox Your Liver with Homemade Lemon Water

Detox Your Liver with Homemade Lemon Water

Pin It

One of the drinks I routinely make for myself and my family in the mornings is lemon water. Not to be confused with “lemonade,” a sweetened beverage, lemon water is a detoxifying health drink consisting of nothing but one whole lemon and warm water.

Much of the research on lemon water’s ability to detoxify the liver is centered around the antioxidant D-Limonene, which is more concentrated in the peel of the lemon. D-limonene has been shown to activate enzymes in the liver that lead to detoxification. It has also been shown to treat cancer.

The Healing Properties of Clove Essential Oil

The Healing Properties of Clove Essential Oil

Pin It

The ancient texts all seem to agree on the many therapeutic properties of clove – it is a stimulant and has stomachic, expectorant, sedative, carminative, antispasmodic and digestive qualities. It helps flatulence, stimulates digestion and restores appetite, so is good for convalescence. It is a general tonic for both physical and intellectual weakness; and for those suffering from frigidity.

Its principal therapeutic value, though, is antiseptic because of the high proportion of eugenol. This is used for intestinal parasites, and for prevention of virus infections. It is good for the immune system, and particularly effective in mouth and tooth infections.

Here is a review of some of scientific studies published around the world regarding the healing properties of clove essential oil.

read more


Get the news right in your inbox!